Objectives—The current study examines the prevalence of health risk behaviors and their cumulative effects on cardiovascular disease (CVD) among a sample of adults. Age cohort is also examined to determine the role of age in predicting CVD and risky health behaviors. Method—Medical records of a sample of adults from the Seattle Longitudinal Study categorized into one of four age-group cohorts w...

Using a conventional thermal chemical vapor deposition (CVD) system, ethanol vapor was enclosed in a reactor, i.e., no flow, with Co/Mo dip-coated quartz substrates to synthesize submillimeter long vertically aligned single-walled carbon nanotube (SWNT) films successfully. The no-flow CVD method yielded an increase in film thickness of up to 0.11 mm compared with the normal flowing gas method f...

LPCVD is a process used in the manufacturing of the deposition of thin films on semiconductors usually ranging from a few nanometers to many micrometers. LPCVD is used to deposit a wide range of possible film compositions with good conformal step coverage. These films include a variety of materials including polysilicon for gate contacts, thick oxides used for isolation, doped oxides for global...

background: although physical activity (pa) has long been associated with cardiovascular disease (cvd), assessment of pa status has never been used as a part of cvd risk prediction tools. the aim of the present work was to examine whether the inclusion of pa status in a cvd risk model improves its predictive accuracy. methods: data from the 10‑year follow‑up (2002–2012) of the n = 2020 particip...

PURPOSE This study aimed to describe and compare refill adherence and persistence to lipid-lowering medicines in patients with type 2 diabetes by previous cardiovascular disease (CVD). METHODS We followed 97 595 patients (58% men; 23% with previous CVD) who were 18 years of age or older when initiating lipid-lowering medicines in 2007-2010 until first fill of multi-dose dispensed medicines, d...

BACKGROUND There is little evidence to inform the targeted treatment of individuals found early in the diabetes disease trajectory. AIM To describe cardiovascular disease (CVD) risk profiles and treatment of individual CVD risk factors by modelled CVD risk at diagnosis; changes in treatment, modelled CVD risk, and CVD risk factors in the 5 years following diagnosis; and how these are patterne...